← Eichor
Study identifier: NCT06113016 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors

Condition: Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8  ·  Sponsor: Jonsson Comprehensive Cancer Center

PhasePhase 2
Planned participants164
Who can joinFemale, N/A to no upper limit
Healthy volunteersNo

About this study

This phase II trial tests how well fisetin and exercise works in preventing frailty in breast cancer survivors. Fisetin is a natural substance found in strawberries and other foods and is available as a nutritional supplement. Nutritional supplements may be useful in eliminating cells that have undergone a process called senescence. Senescence is when a cell ages and permanently stops dividing but does not die. Over time, large numbers of these cells build up in tissues throughout the body and can release harmful substances that cause inflammation and damage nearby healthy cells. Giving fisetin may eliminate senescent cells in patients with breast cancer undergoing physical activity.

This description comes directly from the study's public registry record.

Talk to the study team

Mina S. Sedrak, MD  ·  310-825-3181  ·  msedrak@mednet.ucla.edu

Kelly Synold  ·  424-440-3877  ·  ksynold@mednet.ucla.edu

Always discuss trial participation with your own doctor first.

Locations (6)

UCLA Health Cancer Care in AlhambraAlhambra, California, United StatesRecruiting
UCLA Health Beverly Hills Primary & Specialty CareBeverly Hills, California, United StatesRecruiting
UCLA Health Burbank Primary & Specialty CareBurbank, California, United StatesRecruiting
UCLA / Jonsson Comprehensive Cancer CenterLos Angeles, California, United StatesRecruiting
UCLA Health Primary Care in Marina del ReyMarina del Rey, California, United StatesRecruiting
UCLA Health Primary Care in PasadenaPasadena, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06113016